Allergan Inc. convinced a federal district court to throw out a whistleblower’s suit alleging that the company engaged in an unlawful kickback scheme to promote Botox in pediatric migraine treatments.
This whistleblower failed to provide sufficient evidence that Allergan violated the False Claims Act by making cash to payments to doctors in exchange for referrals to pediatric specialists, Judge Rodney Gilstrap of the US District Court for the Eastern District of Texas said in an order granting Allergan summary judgment. The court placed the order on the docket March 3.
Braeden Hearrell brought claims in 2021 alleging that Allergan knowingly ...
AI-powered legal analytics, workflow tools and premium legal & business news.
Log in to keep reading or access research tools.
On February 26, 2025, the U.S. District Court for the Northern District of Texas issued a significant False Claims Act (FCA) ruling in United States of America ex rel. Cheryl Taylor v. Healthcare ...